Skip to main content

CORRECTION article

Front. Physiol., 10 October 2022
Sec. Clinical and Translational Physiology
Volume 13 - 2022 | https://doi.org/10.3389/fphys.2022.1045550
This article is part of the Research Topic Role of Congestion in Heart Failure: from Bench to Clinical Practice View all 10 articles

Corrigendum: Preclinical models of congestive heart failure, advantages and limitations for application in clinical practice

This article is a correction to:

  1. Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice

    1. Read original article
Marta Saura,Marta Saura1,2Jose Luis Zamorano,Jose Luis Zamorano2,3Carlos Zaragoza, Carlos Zaragoza2,4*
  • 1Departamento de Biología de Sistemas, Facultad de Medicina (IRYCIS), Universidad de Alcalá, Madrid, Spain
  • 2Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
  • 3Departamento de Cardiología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
  • 4Unidad de Investigación Cardiovascular, Departamento de Cardiología, Universidad Francisco de Vitoria, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain

A Corrigendum on
Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice

by Saura M, Zamorano JL and Zaragoza C (2022). Front. Physiol. 13:850301. doi: 10.3389/fphys.2022.850301

In the published article, the Funding statement was omitted by mistake. The correct Funding statement appears below.

“Proyectos de i+D+I, from the program Investigación orientada a los retos de la sociedad, cofounded by Fondo Europeo de Desarrollo Regional (FEDER) A way to achieve Europe (MINECO/AEI/FEDER/EU SAF2017-87342-R)”, and “PDC2021-121817-I00 cofounded by MICIN/AEI/10.13039/501100011033 and European Union Next GenerationEU/PRTR”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: congestive heart failure, large animal models, rodent models, myocardial ischemia, myocardial infarction, hypertension, atherosclerosis, embolization

Citation: Saura M, Zamorano JL and Zaragoza C (2022) Corrigendum: Preclinical models of congestive heart failure, advantages and limitations for application in clinical practice. Front. Physiol. 13:1045550. doi: 10.3389/fphys.2022.1045550

Received: 15 September 2022; Accepted: 22 September 2022;
Published: 10 October 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Saura, Zamorano and Zaragoza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Carlos Zaragoza, Yy56YXJhZ296YS5wcm9mQHVmdi5lcw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.